MedPath
HSA Approval

PREDNISOLONE SYRUP 5 mg/5 ml

SIN09126P

PREDNISOLONE SYRUP 5 mg/5 ml

PREDNISOLONE SYRUP 5 mg/5 ml

January 13, 1997

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.
Licence HolderBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SYRUP

ORAL

Medical Information

H02AB06

prednisolone

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

BEACONS PHARMACEUTICALS PTE LTD

Active Ingredients

PREDNISOLONE SODIUM PHOSPHATE EQV PREDNISOLONE

5 mg/5 ml

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PREDNISOLONE SYRUP 5 mg/5 ml - HSA Approval | MedPath